|
|
||||||||



* Department of Microbiology and Immunology, University of Arizona College of Medicine, Tucson, AZ 85274;
Department of Microbiology, Arizona State University, Tempe, AZ 85287; and
Division of Neurobiology, Barrow Neurological Institute, Phoenix, AZ 85013
There is evidence for both physiological functions of the natural neurotransmitter, acetylcholine, and pharmacological actions of the plant alkaloid, nicotine, on the development and function of the immune system. The effects of continuous exposure to nicotine over a 12-day course of fetal thymus organ culture (FTOC) were studied, and thymocytes were analyzed by flow cytometry. In the presence of very low concentrations of nicotine many more immature T cells (defined by low or negative TCR expression) and fewer mature T cells (intermediate or high expression of TCR) were produced. In addition, the numbers of cells expressing CD69 and, to a lesser extent, CD95 (Fas) were increased. These effects took place when fetal thymus lobes from younger (1314 days gestation) pups were used for FTOC. If FTOC were set up using tissue from older (1516 days gestation pups), nicotine had little effect, suggesting that it may act only on immature T cell precursors. Consistent with an increase in immature cells, the expression of recombinase-activating genes was found to be elevated. Nicotine effects were partially blocked by the simultaneous addition of the nicotinic antagonist d-tubocurarine. Furthermore, d-tubocurarine alone blocked the development of both immature and mature murine thymocytes, suggesting the presence of an endogenous ligand that may engage nicotinic acetylcholine receptors on developing thymocytes and influence the course of normal thymic ontogeny.
This article has been cited by other articles:
![]() |
F.-D. Shi, W.-H. Piao, Y.-P. Kuo, D. I. Campagnolo, T. L. Vollmer, and R. J. Lukas Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity J. Immunol., February 1, 2009; 182(3): 1730 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gong, R. Zhang, J. Zhang, L. Xu, F. Zhang, W. Xu, Y. Wang, Y. Chu, and S. Xiong {alpha}-Dystroglycan is involved in positive selection of thymocytes by participating in immunological synapse formation FASEB J, May 1, 2008; 22(5): 1426 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Gao, D. F. Wan, and J. R. Gu Ex vivo Nicotine Stimulation Augments the Efficacy of Therapeutic Bone Marrow-Derived Dendritic Cell Vaccination Clin. Cancer Res., June 15, 2007; 13(12): 3706 - 3712. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cloez-Tayarani and J.-P. Changeux Nicotine and serotonin in immune regulation and inflammatory processes: a perspective J. Leukoc. Biol., March 1, 2007; 81(3): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yu, J. Mao, Y. Wu, H. Luo, and J. Wu Ephrin-B1 Is Critical in T-cell Development J. Biol. Chem., April 14, 2006; 281(15): 10222 - 10229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Rubin, T. M. Hermanson, E. J. Bedrick, J. D. McDonald, S. W. Burchiel, M. D. Reed, and W. L. Sibbitt Jr. Effect of Cigarette Smoke on Autoimmunity in Murine and Human Systemic Lupus Erythematosus Toxicol. Sci., September 1, 2005; 87(1): 86 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Saeed, S. Varma, T. Peng-Nemeroff, B. Sherry, D. Balakhaneh, J. Huston, K. J. Tracey, Y. Al-Abed, and C. N. Metz Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation J. Exp. Med., April 4, 2005; 201(7): 1113 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Frazer-Abel, S. Baksh, S. P. Fosmire, D. Willis, A. M. Pierce, H. Meylemans, D. S. Linthicum, S. J. Burakoff, T. Coons, D. Bellgrau, et al. Nicotine Activates Nuclear Factor of Activated T Cells c2 (NFATc2) and Prevents Cell Cycle Entry in T Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 758 - 769. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |